Postantibiotic and Sub-Mic Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus Aureus
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02616-18
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
American Society for Microbiology